Navigation Links
Seahorse Bioscience Announces Asia Mito 2012 Travel Award Winners Advancing Cell Metabolism Research
Date:12/7/2012

BILLERICA, Mass., Dec. 7, 2012 /PRNewswire/ -- Seahorse Bioscience, the world leader in instrumentation and assay kits for measuring cell metabolism announces travel award recipients who presented at the Asia Mito 2012 Conference, November 2-5, 2012, in Beijing.

  • Yu Ting Wu, Ph.D., candidate at the Institute of Biochemistry and Molecular Biology, National Yang-Ming University, in Taipei, Taiwan. Poster title: Regulation of Mitochondrial FoF1ATPase Activity by Sirt3-catalyzed Deacetylation and Its Deficiency Elicited by Oxidative Stress in Cells from Patients with CPEO Syndrome.
  • Chien-Tsun Chen, postdoctoral fellow at the Institute of Biochemistry and Molecular Biology, National Yang-Ming University, in Taipei, Taiwan. Poster title: The Role of Sirtuin 3 and Mitochondria in the Function of Adipocytes Differentiated from Human Mesenchymal Stem Cells.
  • Chih-Hao Wang, postdoctoral fellow at the Institute of Biochemistry and Molecular Biology, National Yang-Ming University, in Taipei, Taiwan. Poster title: Cisd2 deficiency leads to impaired differentiation and function of adipocytes in mice.

Seahorse XF Analyzers and stress test kits are the industry standard for simultaneously measuring the two major energy pathways of the cell - mitochondrial respiration and glycolysis - in a microplate, in real-time. XF Analyzers quickly and easily ensure reliable and reproducible data, revealing a new level of detail regarding the interplay between these energy-producing pathways and disease.

"Increasingly studies reveal that Sirt3 plays a pivotal role in the regulation of mitochondrial metabolism. The XF Analyzer has given us the opportunity to explore how Sirt3 mediates energy homeostasis through deacetylating mitochondrial  proteins, and has enhanced our research by helping us further understand the relationship between the Sirt3 deficiency, and compromised aerobic respiratory in mitochondrial diseases," stated Yu Ting Wu, Ph.D 

Seahorse supports the exploration of cell metabolism through travel awards that are offered to graduate students, post-doctoral researchers, and young investigators who present a poster or presentation citing data generated on the XF platform at scientific meetings and conferences. Through this program, Seahorse seeks to increase the body of knowledge that is enabling new discoveries about the role of cell metabolism in pathophysiology.

"We study the metabolic plasticity of stem cells during the stages of differentiation and reprogramming. The ability to decipher the bioenergetic signatures of stem cells has provided invaluable insight into the regulation of self-renewal and pluripotency," stated Chien-Tsun Chen.

"Advancements in XF technology have made possible significant progress in cellular bioenergetics research. I know, and I believe our customers would agree, that XF Analyzers are now the Gold Standard for studying cell metabolism and its relation to disease," stated Richard Huang, President of Cell-Bio Biotechnology Co. Ltd., Seahorse Bioscience's distributor in Taiwan.

XF technology provides the easiest, most advanced, and comprehensive assessment of cell metabolism available in a microplate today. This knowledge is enabling scientists to better understand the connection of physiological traits of cells with genomic and proteomic data, leading to a greater understanding and new treatments of disease.

About Seahorse Bioscience

Seahorse XF Analyzers and stress test kits are the industry standard in cell metabolism measurements. Scientists worldwide are advancing their research in understanding the role of cellular bioenergetics in Cancer, Cardiovascular Disease, Cell Physiology, Immunology, Neurodegeneration, Obesity & Diabetes, Stem Cell Biology, Toxicology, and Translational Medicine. Seahorse is headquartered in Billerica, Massachusetts, U.S., and has offices in Copenhagen, Denmark; and Shanghai, China. http://www.seahorsebio.com/.

About the National Yang-Ming University

National Yang-Ming University is in the Shipai, Beitou District, Taipei, Taiwan and is known for its academic programs in relation to Medicine, Life Sciences and Biotechnology. http://nymu-e.web.ym.edu.tw/front/bin/home.phtml.

Press Contact:
Cynthia Egan
Director of Marketing
Seahorse Bioscience
cegan@seahorsebio.com
978-671-1600


'/>"/>
SOURCE Seahorse Bioscience
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
2. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
3. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
4. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
5. Pressure BioSciences Partners with Constant Systems to Significantly Expand Product Offerings and International Distribution
6. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
7. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
8. 3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for the Study of Liver Disease Annual Meeting 2012
9. Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinsons Blood Test Joint Venture
10. IntelliCell BioSciences Announces FDA Registration for its Cell Processing Facility
11. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
(Date:2/23/2017)... , Feb. 23, 2017 Visiomed, ... and services since 1997, is changing the landscape ... technology providing patients with pro-active, custom-made solutions. Recognizing ... for instant and affordable healthcare without walls, Visiomed ... high-level devices developed with healthcare professionals that is ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... With millions of Americans ... important that we all are aware of our options and are empowered with ... announce the launch of its newest edition of "Vision and Hearing" in USA ...
(Date:2/24/2017)... Viejo, CA (PRWEB) , ... February 24, 2017 , ... ... Final Cut Pro X . Users have total control over position, rotation, distortion, ... and more all within Final Cut Pro X. , With ProGlass Prism users are ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals (iaedp) ... You See” body image mannequin art competition. Selected from 15 submissions from around the ... revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... services, which specializes in thought leadership , media relations, social media, content ... services that will be powered through Act-On, an intuitive marketing automation platform. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
Breaking Medicine News(10 mins):